# Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

> **NCT03935984** · PHASE4 · RECRUITING · sponsor: **Joseph Sferra** · enrollment: 37 (estimated)

## Conditions studied

- Primary Hyperparathyroidism
- Hypercalcemia

## Interventions

- **DRUG:** Calcitonin

## Key facts

- **NCT ID:** NCT03935984
- **Lead sponsor:** Joseph Sferra
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-29
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935984, "Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03935984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*